Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022–May 2023

Author:

Plumb Ian D.ORCID,Briggs Hagen Melissa,Wiegand RyanORCID,Dumyati GhinwaORCID,Myers Christopher,Harland Karisa K.ORCID,Krishnadasan Anusha,James Gist Jade,Abedi Glen,Fleming-Dutra Katherine E.,Chea Nora,Lee Jane E.,Kellogg MelissaORCID,Edmundson Alexandra,Britton Amber,Wilson Lucy E.ORCID,Lovett Sara A.ORCID,Ocampo Valerie,Markus Tiffanie M.ORCID,Smithline Howard A.ORCID,Hou Peter C.ORCID,Lee Lilly C.,Mower WilliamORCID,Rwamwejo Fernand,Steele Mark T.,Lim Stephen C.ORCID,Schrading Walter A.,Chinnock Brian,Beiser David G.ORCID,Faine BrettORCID,Haran John P.ORCID,Nandi Utsav,Chipman Anne K.,LoVecchio FrankORCID,Eucker StephanieORCID,Femling Jon,Fuller Matthew,Rothman Richard E.,Curlin Marcel E.,Talan David A.,Mohr Nicholas M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference56 articles.

1. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study;Watson;Lancet Infect Dis,2022

2. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

3. BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5;Tartof;Lancet Infect Dis,2022

4. Effectiveness of a messenger RNA vaccine booster dose against coronavirus disease. Open forum 2019 among US healthcare personnel, October 2021–July 2022;Plumb;Infect Dis,2023

5. Interim recommendations from the advisory committee on immunization practices for the use of bivalent booster doses of COVID-19 vaccines - United States, October 2022;Rosenblum;MMWR Morb Mortal Wkly Rep,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3